BridgeMD
New treatment option for Anterior Cruciate Ligament Injuries
Official title Effect of Early Gait Training on Knee Cartilage Degeneration After Anterior Cruciate Ligament Reconstruction
ClinicalTrials.gov ID: NCT06368544
What this study is testing
- What it's testing
- A randomized controlled clinical study was conducted to elucidate the relationship between the lower extremity biomechanics of patients undergoing early gait training after ACLR surgery.The relationship between the biochemical characteristics of cartilage and the biomechanical risk index were proposed to providing exercise guidance and training for ACLR people and it is suggested that it can prevent and reduce the risk of cartilage degeneration early after operation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40
You may be able to join if
- Patients with ACL rupture were diagnosed by MRI;
- Unilateral ACL rupture for the first time should be performed in our hospital (Department of Sports Medicine, Peking University Third Hospital)The...
- Normal BMI range: 18.5-23.9 kg/m2;
- Within 6 months from the trauma;
- The affected knee joint has passed the acute stage, no obvious redness, pain,inflammation, and limited joint motion,basically restore joint motion.
You likely can't join if
- BMI\<18.5 kg/m2 or BMI≥24 kg/m2);
- There is a history of contralateral lower limb musculoskeletal system injury and surgery;
- ACL injury time \> 6 months;
- Outerbridge damage rating Ⅲ and Ⅳ;
- Patients with meniscal tears who are expected to undergo meniscal suture surgery at the time of ACLR surgery;
- Serious injury to the posterior cruciate ligament, medial collateral ligament, or lateral collateral ligament;
See the full eligibility criteria
- Patients with ACL rupture were diagnosed by MRI;
- Unilateral ACL rupture for the first time should be performed in our hospital (Department of Sports Medicine, Peking University Third Hospital)The art of reconstruction;
- Normal BMI range: 18.5-23.9 kg/m2;
- Within 6 months from the trauma;
- The affected knee joint has passed the acute stage, no obvious redness, pain,inflammation, and limited joint motion,basically restore joint motion.
- BMI\<18.5 kg/m2 or BMI≥24 kg/m2);
- There is a history of contralateral lower limb musculoskeletal system injury and surgery;
- ACL injury time \> 6 months;
- Outerbridge damage rating Ⅲ and Ⅳ;
- Patients with meniscal tears who are expected to undergo meniscal suture surgery at the time of ACLR surgery;
- Serious injury to the posterior cruciate ligament, medial collateral ligament, or lateral collateral ligament;
- There is metabolic syndrome (obesity, dyslipidemia, diabetes, etc.), which will involve articular cartilage Epidemic diseases, serious cardiovascular and cerebrovascular diseases, etc.;
- Those who do not want to accept this treatment
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.